Display options
Cite
Yeddi A, Adam O, Khalid M, et al. 5-Fluorouracil-Associated Cardiogenic Shock. Am J Ther. 2019;28(6):e779-e781doi: 10.1097/MJT.0000000000001129.
Yeddi, A., Adam, O., Khalid, M., Farah, Y., Yeddi, O., Shereef, H., Yassin, A., Yeddi, M., Ghandour, M., Omer, M., Elawad, A., & Salih, L. (2019). 5-Fluorouracil-Associated Cardiogenic Shock. American journal of therapeutics, 28(6), e779-e781. https://doi.org/10.1097/MJT.0000000000001129
Yeddi, Ahmed, et al. "5-Fluorouracil-Associated Cardiogenic Shock." American journal of therapeutics vol. 28,6 (2019): e779-e781. doi: https://doi.org/10.1097/MJT.0000000000001129
Yeddi A, Adam O, Khalid M, Farah Y, Yeddi O, Shereef H, Yassin A, Yeddi M, Ghandour M, Omer M, Elawad A, Salih L. 5-Fluorouracil-Associated Cardiogenic Shock. Am J Ther. 2019 Dec 31;28(6):e779-e781. doi: 10.1097/MJT.0000000000001129. PMID: 31904593.
Copy Download .nbib Format: NLM
Share it on

Am J Ther. 2019 Dec 31;28(6):e779-e781. doi: 10.1097/MJT.0000000000001129.

5-Fluorouracil-Associated Cardiogenic Shock.

American journal of therapeutics

Ahmed Yeddi, Omeralfaroug Adam, Mowyad Khalid, Yasir Farah, Omer Yeddi, Hammam Shereef, Ahmed Yassin, Mohammed Yeddi, Mohamedanwar Ghandour, Mohamed Omer, Ayman Elawad, Lubna Salih

Affiliations

  1. Department of Internal Medicine, Wayne State University, Detroit, MI.
  2. Department of Internal Medicine, St. Mary Mercy Hospital, Livonia, MI.
  3. Department of Toxicology, Omudrman Islamic University, Sudan.
  4. Department of Internal Medicine, Beaumont Hospital, Dearborn, MI.
  5. Department of Internal Medicine, Rashid Hospital, Dubai, United Arab Emirates.
  6. Department of Nephrology, Wayne State University Detroit, MI.
  7. Department of Community medicine, Mayo clinic, Jacksonville, FL.
  8. University of Medical Sciences and Technology, Khartoum, Sudan.
  9. Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Sudan.

PMID: 31904593 DOI: 10.1097/MJT.0000000000001129

[No abstract available.]

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

  1. Sara JD, Kaur J, Khodadadi R, et al. 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol. 2018;10:1758835918780140. - PubMed
  2. Basselin C, Fontanges T, Descotes J, et al. 5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy. 2011;31:226. - PubMed
  3. Ozturk MA, Ozveren O, Cinar V, et al. Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood Coagul Fibrinolysis. 2013;24:90–94. - PubMed
  4. Akhtar SS, Wani BA, Bano ZA, et al. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report. Tumori. 1996;82:505–507. - PubMed
  5. David JS, Gueugniaud PY, Hepp A, et al. Severe heart failure secondary to 5-fluorouracil and low-doses of folinic acid: usefulness of an intra-aortic balloon pump. Crit Care Med. 2000;28:3558–3560. - PubMed
  6. Bakouboula B, Morel O, Douchet MP, et al. Reversible cardiogenic shock under 5-fluorouracil treatment [in French]. Ann Cardiol Angeiol (Paris). 2005;54:216–219. - PubMed
  7. Ferte C, Gomez Roca C, Loriot Y, et al. Reversible cardiogenic shock following 5-fluorouracil infusion. Invest New Drugs. 2010;28:531–533. - PubMed
  8. Arnold AZ, Razavi M. Right heart failure after chemotherapy. Cleve Clin J Med. 1991;58:357–360. - PubMed
  9. Dechant C, Baur M, Bock R, et al. Acute reversible heart failure caused by coronary vasoconstriction due to continuous 5-fluorouracil combination chemotherapy. Case Rep Oncol. 2012;5:296–301. - PubMed
  10. Sulpher J, Dattilo F, Dent S, et al. Acute cardiogenic shock induced by infusional 5-Fluorouracil. Case Rep Oncol Med. 2014;2014:819396. - PubMed
  11. Polk A, Vaage-Nilsen M, Vistisen K, et al. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 2013;39:974–984. - PubMed
  12. Rateesh S, Shekar K, Naidoo R, et al. Use of extracorporeal membrane oxygenation for mechanical circulatory support in a patient with 5-fluorouracil induced acute heart failure. Circ Heart Fail. 2015;8:381–383. - PubMed
  13. Amraotkar AR, Pachika A, Grubb KJ, et al. Rapid extracorporeal membrane oxygenation overcomes fulminant myocarditis induced by 5Fluorouracil. Tex Heart Inst J. 2016;43:178–182. - PubMed

Publication Types